Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 8, 2008, Pages 1476-1480

  Conner, Alex C ^a,b   Kissling, Christian ^a   Hodges, Edward ^a   Hünnerkopf, Regina ^a   Clement, R Marc ^a   Dudley, Edward ^a   Freitag, Christine M ^c   Rösler, Michael ^c   Retz, Wolfgang ^c   Thome, Johannes ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

ADHD; Genetic association; Neurotrophic factor; Single nucleotide polymorphisms; Synaptic vesicle protein

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EXON; FORENSIC PSYCHIATRY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NTF3 GENE; NTRK2 GENE; NTRK3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; EXONS; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NEUROTROPHIN 3; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUESTIONNAIRES; RISK FACTORS;

EID: 57349184756     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30632     Document Type: Article

References (33)

1. Adler CM, Delbello MP, Mills NP, Schmithorst V, Holland S, Strakowski SM. 2005. Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord 7(6):577-588.
2. Barkley RA, Fischer M, Smallish L, Fletcher K. 2002. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111(2):279-289.
3. Barkley RA, Murphy JV. 1978. Pseudodeterioration of intelligence in children. Ann Neurol 4(4):388.
4. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. 1990. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29(4):526-533.
5. Blochl A, Blochl R. 2007. A cell-biological model of p75(NTR) signaling. J Neurochem 102: 289-305.
6. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML. 2001. Prevalence and assessment of attention-deficit/ hyperactivity disorder in primary care settings. Pediatrics 107(3):E43.
7. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, et al. 2005. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 134B(1):110-114.
8. Dvornyk V, Long JR, Xiong DH, Liu PY, Zhao LJ, Shen H, Zhang YY, Liu YJ, Rocha-Sanchez S, Xiao P, et al. 2004. Current limitations of SNP data from the public domain for studies of complex disorders: A test for ten candidate genes for obesity and osteoporosis. BMC Genet 5:4.
9. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
10. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, Tannock R, Roberts W, Malone M, Swanson J, Kennedy JL, Barr CL. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 2005. 10(11):998-1005, 973.
11. Hattori M, Kunugi H, Akahane A, Tanaka H, Ishida S, Hirose T, Morita R, Yamakawa K, Nanko S. 2002. Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia. Am J Med Genet 114(3):304-309.
12. Hünnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP. 2007. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 32: 2552-2560.
13. Kent L, Green E, Hawi Z, Kirley A, Dudbridge F, Lowe N, Raybould R, Langley K, Bray N, Fitzgerald M, et al. 2005. Association of the paternally transmitted copy of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry 10(10):939-943.
14. Kissling C, Retz W, Wiemann S, Coogan A, Clement R, Hünnerkopf R, Conner A, Freitag C, Rösler M, Thome J. 2007. A polymorphism at the 3′-untranslated region of the clock gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (in press).
15. Kordon A, Kahl KG, Wahl K. 2006. A new understanding of attention-deficit disorders-beyond the age-at-onset criterion of DSM-IV. Eur Arch Psychiatry Clin Neurosci 256 (Suppl 1):i47-i54.
16. Kustanovich V, Merriman B, Mcgough J, Mccracken JT, Smalley SL, Nelson SF. 2003. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry 8(3):309-315.
17. Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM, Simmons DA. 2007. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci 27(16):4424-4434.
18. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ. 2004. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101(29):10827-10832.
19. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ. 2007. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61(2):187-197.
20. Neuman RJ, Heath A, Reich W, Bucholz KK, Madden PAF, Sun L, Todd RD, Hudziak JJ. 2001. Latent class analysis of ADHD and comorbid symptoms in a population sample of adolescent female twins. J Child Psychol Psychiatry 42(7):933-942.
21. Retz W, Retz-Junginger P, Supprian T, Thome J, Rösler M. 2004. Association of serotonin promoter gene polymorphism with violence: Relation with personality disorders, impulsivity and childhood ADHD psychopathology. Behav Sci Law 22(3):415-425.
22. Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, Wender PH, Rösler M. 2003. Reliability and validity of the Wender-Utah-rating-scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Nervenarzt 74(11):987-993.
23. Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, Schwitzgebel P, Pinhard K, Dovi-Akue N, Wender P. et al. 2004. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254(6):365-371.
24. Rösler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. 2006. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256 (Suppl 1):i3-i11.
25. Rowland AS, Lesesne CA, Abramowitz AJ. 2002. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view. Ment Retard Dev Disabil Res Rev 8(3):162-170.
26. Schimmelmann BG, Friedel S, Dempfle A, Warnke A, Lesch KP, Walitza S, Renner TJ, Romanos M, Herpertz-Dahlmann B, Linder M, et al. 2007. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J Neural Transm 114(4):523-526.
27. Syed Z, Dudbridge F, Kent L. 2007. An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am J Med Genet B Neuropsychiatr Genet 144B(3):375-378.
28. Thapar A, Langley K, O'Donovan M, Owen M. 2006. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol Psychiatry 11(8):714-720.
29. Thapar A, Langley K, Owen MJ, O'Donovan MC. 2007. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med 37:1681-1692.
30. Thome J, Durany N, Palomo A, Foley P, Harsanyi A, Baumer A, Hashimoto E, Cruz-Sanchez FF, Riederer P. 1997. Variants in neurotrophic factor genes and schizophrenic psychoses: No associations in a Spanish population. Psychiatry Res 71(1):1-5.
31. Tsai SJ. 2007. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: Clinical and therapeutic implications. Med Hypotheses 68(4):896-899.
32. Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah rating scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150(6):885-890.
33. Wender EH. 1995. Attention-deficit hyperactivity disorders in adolescence. J Dev Behav Pediatr 16(3):192-195.